Work

Abstract 3003: Targeting mechanisms of adaptive resistance to the PI3Kαmutant selective inhibitor RLY-2608 in HR+/PIK3CA mutant breast cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

Authors: Fabiana Napolitano, Chang-Ching Lin, Khushi Ahuja, Dan Ye, María Rosario Chica-Parrado, Yasuaki Uemoto, Pamela Luna, Yuki Matsunaga, Saurabh Mendiratta, Nisha Unni, Jeon Lee, Ariella B. Hanker, Carlos L. Arteaga

Institutions: Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409633804

Cites:

Cited by: 1

Related to: 10